For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Psyence Biomedical Ltd (NASDAQ: PBM) closed the day trading at $1.49 down -13.37% from the previous closing price of $1.72. In other words, the price has decreased by -$13.37 from its previous closing price. On the day, 0.62 million shares were traded. PBM stock price reached its highest trading level at $1.72 during the session, while it also had its lowest trading level at $1.45.
Ratios:
For a better understanding of PBM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.09 and its Current Ratio is at 8.09. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 1062717 and an Enterprise Value of -5936322.
Stock Price History:
The Beta on a monthly basis for PBM is 0.43, which has changed by -0.9482639 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $62.72, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is -54.06%, while the 200-Day Moving Average is calculated to be -68.82%.
Shares Statistics:
Over the past 3-months, PBM traded about 890.02K shares per day on average, while over the past 10 days, PBM traded about 2136900 shares per day. Insiders hold about 0.00% of the company’s shares, while institutions hold 9.37% stake in the company. Shares short for PBM as of 1761868800 were 78860 with a Short Ratio of 0.09, compared to 1759190400 on 66121. Therefore, it implies a Short% of Shares Outstanding of 78860 and a Short% of Float of 33.660000000000004.
